Our results may partly alleviate this concern, where the rates of breast surgery, radiotherapy, chemotherapy, endocrine therapy and anti-HER2 therapy seemed similar between those with or without prior thyroid gland cancer. The gene discussed is ERBB2; the disease is thyroid cancer.